South Shore Health is among five healthcare organizations which has been granted funding to expand access to postpartum and newborn care across Massachusetts. The state’s Health Policy Commission recently approved $1.4m in awards to five applicants for the Cost-Effective, Coordinated Care for...

South Shore Health has announced the return of wig services, which was once offered by The Boutique during its tenure in the Dana Farber/Brigham Cancer Center at South Shore Health. Wig services will now have a permanent home within the Gift Shop, located inside the McKim entrance to South Shore...

The Friends of South Shore Health will host the Set the Pace road race on Saturday, Oct. 2!

Did you know that the Bridge Program, part of the Grayken Center for Treatment at South Shore Health has treated 1,765 people and performed 14,236 office visits since its inception? And, through the efforts of the nationally-sponsored, Weymouth-based HEAL (Helping End Addiction Long-term) Initiative...

As demand and need for COVID-19 testing increases, employees and residents of Weymouth now have access to town-sponsored services. South Shore Hospital, part of South Shore Health, will provide testing kits, supplies and clinicians to administer tests. The tests are free to town of Weymouth...

South Shore Health has taken additional steps to minimize the risk of spreading COVID-19. Get the details in this update.

​​​​​​​The Friends of South Shore Health are hosting their signature Kickin' Up Country for Home Care dinner dance on Saturday, June 4, 2022 at South Shore Country Club in Hingham.

Dr. Jason Tracy, Chief of Emergency Medicine at South Shore Hospital recently spoke with WCVB-TV about the opioid crisis in Massachusetts. Watch the video.

The new GE Ascend CT scanner, the second of its kind in the U.S., uses artificial intelligence and is designed to improve workflow and patient comfort, while providing superior image quality.

The FDA has approved a new flu medication in the form of a single-dose pill. South Shore Hospital's Todd Ellerin, an infectious disease expert, spoke with ABC News and weighs-in on the new drug.